With earnings season now over, the market is more vulnerable to a pullback than ever. Read More

There's still plenty of upside for our Income Portfolio's trio of MLPs. Read More

With the growing number of risks haunting ETNs, it may be prudent to stay clear of them. Read More

Despite losing one of its blockbuster patents, this Income Portfolio pharma has plenty left in the pipeline. Read More

Article in Review: “Best of Both Worlds,” by Yiannis Mostrous, May 11, 2011 Read More

Here’s why the unemployment rate in the US is actually worse than it appears. Read More

A batch of weak economic indicators combined with smoldering geopolitical tensions in Europe all point to a summer sell-off for the market. Read More

Here’s why unseasonably warm weather this year has been a mixed blessing for the markets.   Read More